Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02020876 · ClinicalTrials.gov registry record
Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations
A clinical trial, sponsored by GenomeDx Biosciences.
- Completed
- Registry status
- 21
- Enrollment target
NCT02020876: Completed study, sponsored by GenomeDx Biosciences.
NCT02020876 is a clinical trial that has completed, run by GenomeDx Biosciences. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02020876 has completed, sponsored by GenomeDx Biosciences.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
This clinical utility study pilot is based on a review of real but de-identified and randomized patient cases and aims to evaluate Urologists' treatment recommendations before and after reviewing the results provided by the Decipher test. This is a pilot study and the primary intent is to help guide development and design of future clinical utility studies for Decipher
Primary Outcome
To determine the extent to which the use of the Decipher test influences treatment recommendations by physicians post radical prostatectomy (RP). This decision impact study aims to evaluate Urologists' treatment recommendations before and after reviewing the results provided by the Decipher test.
Interventions
- OTHER DECIPHER Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2012-08 |
| Est. Completion | 2013-12 |
What the finished NCT02020876 record still lists
NCT02020876 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which DECIPHER Questionnaire is the first listed.
NCT02020876 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02020876 about?
NCT02020876 is a clinical study titled "Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations". This clinical utility study pilot is based on a review of real but de-identified and randomized patient cases and aims to evaluate Urologists' treatment recommendations before and after reviewing the results provided by the Decipher test. This is a pilot study and the primary intent is to help guide...
What is the current status of trial NCT02020876?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2012-08. Estimated completion is 2013-12.
What interventions are being tested in trial NCT02020876?
The interventions under investigation include: DECIPHER Questionnaire (OTHER).
Who is sponsoring clinical trial NCT02020876?
This trial is sponsored by GenomeDx Biosciences, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia